These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25994065)

  • 1. Current use of silkworm larvae (Bombyx mori) as an animal model in pharmaco-medical research.
    Nwibo DD; Hamamoto H; Matsumoto Y; Kaito C; Sekimizu K
    Drug Discov Ther; 2015 Apr; 9(2):133-5. PubMed ID: 25994065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of anti-diabetic drugs by using silkworm, Bombyx mori.
    Matsumoto Y; Sekimizu K
    Drug Discov Ther; 2016 Feb; 10(1):19-23. PubMed ID: 26961328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction of a Platform for the Development of Pharmaceutical and Medical Applications Using Transgenic Silkworms].
    Sezutsu H; Sumitani M; Kondo M; Kobayashi I; Takasu Y; Suzuki T; Yonemura N; Iizuka T; Uchino K; Tamura T; Tsubota T; Tatematsu KI
    Yakugaku Zasshi; 2018; 138(7):863-874. PubMed ID: 29962462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of silkworm as a host animal for understanding pathogenicity of Cryptococcus neoformans.
    Ishii M; Matsumoto Y; Sekimizu K
    Drug Discov Ther; 2016 Feb; 10(1):9-13. PubMed ID: 26902902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hyperglycemic silkworm model for evaluating hypoglycemic activity of Rehmanniae Radix, an herbal medicine.
    Matsumoto Y; Sekimizu K
    Drug Discov Ther; 2016 Feb; 10(1):14-8. PubMed ID: 26902904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of host-pathogen interactions and immune-related drug development using the silkworm: interdisciplinary immunology, microbiology, and pharmacology studies.
    Ishii K; Hamamoto H; Sekimizu K
    Drug Discov Ther; 2015 Aug; 9(4):238-46. PubMed ID: 25865526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the silkworm (Bombyx mori) be used as a human disease model?
    Tabunoki H; Bono H; Ito K; Yokoyama T
    Drug Discov Ther; 2016 Feb; 10(1):3-8. PubMed ID: 26853920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silkworm larvae as an animal model of bacterial infection pathogenic to humans.
    Kaito C; Akimitsu N; Watanabe H; Sekimizu K
    Microb Pathog; 2002 Apr; 32(4):183-90. PubMed ID: 12079408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progress and future of enhancing antiviral capacity by transgenic technology in the silkworm Bombyx mori.
    Jiang L; Xia Q
    Insect Biochem Mol Biol; 2014 May; 48():1-7. PubMed ID: 24561307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of lysocin E using a silkworm model of bacterial infection.
    Hamamoto H; Sekimizu K
    Drug Discov Ther; 2016 Feb; 10(1):24-9. PubMed ID: 26911796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding of bacterial virulence using the silkworm infection model.
    Kaito C
    Drug Discov Ther; 2016 Feb; 10(1):30-3. PubMed ID: 26971552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silkworm as a model animal to evaluate drug candidate toxicity and metabolism.
    Hamamoto H; Tonoike A; Narushima K; Horie R; Sekimizu K
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Apr; 149(3):334-9. PubMed ID: 18804554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silkworm model for
    Paudel A; Furuta Y; Higashi H
    Virulence; 2021 Dec; 12(1):2285-2295. PubMed ID: 34490836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Identification of novel therapeutically effective antibiotics using silkworm infection model].
    Hamamoto H; Urai M; Paudel A; Horie R; Murakami K; Sekimizu K
    Yakugaku Zasshi; 2012; 132(1):79-84. PubMed ID: 22214583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a simple evaluation system for the intestinal absorption of an orally administered medicine using Bombyx mori larvae.
    Ichino F; Bono H; Nakazato T; Toyoda A; Fujiyama A; Iwabuchi K; Sato R; Tabunoki H
    Drug Discov Ther; 2018; 12(1):7-15. PubMed ID: 29553084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of an arginine kinase as a major allergen from silkworm (Bombyx mori) larvae.
    Liu Z; Xia L; Wu Y; Xia Q; Chen J; Roux KH
    Int Arch Allergy Immunol; 2009; 150(1):8-14. PubMed ID: 19339797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discovery for antibiotics in an in vivo-mimic infection model using silkworm larvae].
    Uchida R; Tomoda H
    Seikagaku; 2014 Oct; 86(5):595-602. PubMed ID: 25509326
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular mechanism and potential application of bacterial infection in the silkworm, Bombyx mori.
    Wang Q; Sun Z; Ma S; Liu X; Xia H; Chen K
    Dev Comp Immunol; 2022 Jun; 131():104381. PubMed ID: 35245606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Usefulness of Silkworms as a Model Animal for Evaluating the Effectiveness of Medicine and Food].
    Sekimizu K
    Yakugaku Zasshi; 2017; 137(5):551-562. PubMed ID: 28458287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and methods for prevention of Enterococcus mundtii infection in silkworm larvae, Bombyx mori, reared on artificial diet.
    Nwibo DD; Matsumoto Y; Sekimizu K
    Drug Discov Ther; 2015 Jun; 9(3):184-90. PubMed ID: 26193940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.